Driving CARs to new places: locally produced BCMA CAR T cells to treat multiple myeloma
Haematologica
.
2023 Jul 1;108(7):1721-1723.
doi: 10.3324/haematol.2022.282053.
Authors
Maria Sjöstrand
1
,
Michel Sadelain
2
Affiliations
1
Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY.
2
Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY. m-sadelain@ski.mskcc.org.
PMID:
36794501
PMCID:
PMC10316265
DOI:
10.3324/haematol.2022.282053
No abstract available
Publication types
Editorial
MeSH terms
B-Cell Maturation Antigen
Humans
Immunotherapy, Adoptive
Multiple Myeloma* / therapy
Receptors, Chimeric Antigen* / genetics
T-Lymphocytes
Substances
B-Cell Maturation Antigen
Receptors, Chimeric Antigen